Valens Semiconductor (VLN) SVP details initial share and option stakes

Rhea-AI Filing Summary

Valens Semiconductor Ltd. senior vice president of human resources Nelly Elkavets filed an initial ownership report showing her equity position in the company. The Form 3 lists several stock option grants over ordinary shares with exercise prices of $0.75, $0.86 and $2.27, expiring between 2028 and 2032.

The filing also shows direct holdings of ordinary shares, with individual line items including 62,208, 60,501 and 75,000 shares. Footnotes explain that some shares were issued upon vesting of previously granted restricted stock units and that certain options are fully vested and immediately exercisable, while others vest on specified future anniversary dates.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Elkavets Nelly

(Last) (First) (Middle)

8 HANAGAR ST.

POB 7152

(Street)

HOD HASHARON 4501309

(City) (State) (Zip)

ISRAEL

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/20/2026

3. Issuer Name and Ticker or Trading Symbol
Valens Semiconductor Ltd. [ VLN ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP, Human Resources

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares	62,208(1)	D
Ordinary Shares	60,501(2)	D
Ordinary Shares	62,208(3)	D
Ordinary Shares	75,000(4)	D
Ordinary Shares	75,000(5)	D
Ordinary Shares	75,000(6)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	11/15/2016(7)	11/15/2028	Ordinary Shares	13,293	$0.75	D
Stock Option (Right to Buy)	01/11/2021(7)	01/11/2029	Ordinary Shares	21,616	$0.86	D
Stock Option (Right to Buy)	01/11/2022(7)	01/11/2029	Ordinary Shares	21,616	$0.86	D
Stock Option (Right to Buy)	01/11/2020(7)	01/11/2029	Ordinary Shares	21,616	$0.86	D
Stock Option (Right to Buy)	01/11/2022(7)	01/11/2031	Ordinary Shares	46,377	$0.86	D
Stock Option (Right to Buy)	06/26/2027(8)	06/26/2032	Ordinary Shares	127,500	$2.27	D

Explanation of Responses:

1. These shares were issued upon vesting of previously granted RSU's

2. The shares reported herein were acquired upon the exercise of previously granted stock options

3. The Reporting Person was granted restricted stock units ("RSUs"), which each represent a contingent right to receive one share of ordinary stock of Valens Semiconductor Ltd. (the "Company"). The units vest 25% on the first Vesting Date (01/18/2024) and the remaining 75% vest in twelve equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Company or its subsidiaries through each vesting date.

4. The Reporting Person was granted restricted stock units ("RSUs"), which each represent a contingent right to receive one share of ordinary stock of Valens Semiconductor Ltd. (the "Company"). The units vest 25% on the first Vesting Date (01/22/2025) and the remaining 75% vest in twelve equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Company or its subsidiaries through each vesting date.

5. The Reporting Person was granted restricted stock units ("RSUs"), which each represent a contingent right to receive one share of ordinary stock of Valens Semiconductor Ltd. (the "Company"). The units vest 25% on the first Vesting Date (01/23/2026) and the remaining 75% vest in twelve equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Company or its subsidiaries through each vesting date.

6. The Reporting Person was granted restricted stock units ("RSUs"), which each represent a contingent right to receive one share of ordinary stock of Valens Semiconductor Ltd. (the "Company"). The units vest 25% on the first Vesting Date (02/24/2027) and the remaining 75% vest in twelve equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Company or its subsidiaries through each vesting date.

7. The Stock Options are Fully vested and immediately exercisable

8. The Options vest in full on the second year anniversary of the grant (06/26/2027), subject to the Reporting Person's continued service to the Company or its subsidiaries on the vesting date.

Remarks:

This Form 3 is being filed to report the Reporting Persons beneficial ownership of securities of the Issuer as of the date the Reporting Person became subject to the reporting requirements of Section 16 of the Securities Exchange Act of 1934.

	Nelly Elkavets by: Oppenheimer Israel, as Attorney-in-fact	03/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does Valens Semiconductor (VLN) disclose in this Form 3?

The Form 3 discloses SVP of Human Resources Nelly Elkavets’ existing equity holdings, including multiple stock option grants and ordinary shares. It establishes her starting ownership position as an insider, rather than reporting new open-market purchases or sales.

What stock options does Nelly Elkavets hold in Valens Semiconductor (VLN)?

She holds several stock option grants over ordinary shares with exercise prices of $0.75, $0.86 and $2.27. These options have expiration dates ranging from 2028 to 2032, reflecting both older and more recent grants under Valens’ equity plans.

What ordinary share holdings are reported for Nelly Elkavets at Valens (VLN)?

The filing lists multiple direct ordinary share entries, including line items of 62,208, 60,501 and 75,000 shares. These figures represent specific recorded positions rather than a single aggregated total, and they form part of her overall equity stake in Valens.

How were some of the Valens (VLN) shares reported on the Form 3 acquired?

A footnote states that certain shares were issued upon vesting of previously granted restricted stock units. Another footnote explains that additional shares were acquired when earlier stock options were exercised, converting option rights into ordinary shares of Valens Semiconductor.

What are the vesting terms for Nelly Elkavets’ RSUs at Valens (VLN)?

The Form 3 notes several restricted stock unit grants that each convert into one ordinary share upon vesting. Each grant vests 25% on an initial vesting date, with the remaining 75% vesting in twelve equal quarterly installments, contingent on continued service to Valens or its subsidiaries.

Are any of Nelly Elkavets’ Valens (VLN) stock options fully vested?

Yes. A footnote specifies that certain stock options are fully vested and immediately exercisable. Another grant is scheduled to vest in full on the second anniversary of its grant date, provided she continues her service with Valens Semiconductor or its subsidiaries through that vesting date.